| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
January 26, 2012 |
|
|
| |
|
|
| |
|
|
|
CfPA - The Center for Professional Advancement, Amsterdam, The Netherlands
13-14 June 2012
Who Should Attend
This course is intended for individuals from:
• Product Development
• Regulatory Affairs
• Quality Assurance
• Analytical Development
• Process Development
• Quality Control
• Package Engineering
• Manufacturing
• Project Management and Planning
Participants will benefit by gaining a better understanding of the complexities of technology transfer of various dosage forms in the pharmaceutical industry. Description
This course will provide a basic understanding of the technology transfer of analytical methods, quality control standards, packaging components/operations and various pharmaceutical dosage forms from R&D to manufacturing. It is designed to provide an understanding of the issues affecting the transfer within and outside a company. Topics will include transfer of technology to/from international sites as well as to/from third parties. Regulatory requirements and recommended approaches will be discussed. Speakers will use practical examples to highlight issues critical to successful technology transfer. Best practices from several pharmaceutical companies and contract manufacturers will be presented and contrasted.
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA - The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Walter G. Chambliss, Ph.D.; Professor of Pharmaceutics, University of Mississippi
Walter G. Chambliss, Ph.D., is Director of Technology Management and Professor of Pharmaceutics at the University of Mississippi where he is responsible for managing the intellectual property of the University. He received a B.S. in Pharmacy in 1977, a M.S. in Pharmaceutics in 1980 and a Ph.D. in Pharmaceutics in 1982 from the University of Mississippi. He joined the University in 1999 as Associate Director in the National Center for Natural Products Research. He worked for 17 years in research and development in the pharmaceutical industry at G.D. Searle, Bristol-Myers and Schering-Plough where he was Vice President of R&D for the HealthCare Products Division. He has extensive experience in formulation development and process development of a wide variety of dosage forms. Dr. Chambliss is a Fellow of the American Pharmaceutical Association and an active member of APhA-APRS, AAPS, the Licensing Executive Society and the Association of University Technology Managers and has authored or co-authored over twenty publications including three book chapters in pharmaceutical research.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|